Picture of Cytek Biosciences logo

CTKB — Cytek Biosciences News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Brief: Cytek Biosciences Reports Second Quarter 2022 Financial Results

Aug 10 (Reuters) - Cytek Biosciences Inc  CTKB.O :
    * CYTEK BIOSCIENCES REPORTS SECOND QUARTER 2022 FINANCIAL
RESULTS
    * Q2 REVENUE ROSE 32 PERCENT TO $40.2 MILLION
    * QTRLY LOSS PER SHARE $0.00
    * CONTINUES TO EXPECT FULL YEAR 2022 REVENUE TO BE CLOSER TO
THE
HIGH END OF THE RANGE OF $160 MILLION TO $168 MILLION

Source text for Eikon:  ID:nGNX65Qcmz 
Further company coverage:  CTKB.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Cytek Biosciences

See all news